Submitters Still Confused On Adverse Event Reporting To ClinicalTrials.gov
This article was originally published in The Gray Sheet
Executive Summary
Device and drug firms that submit details about their clinical trials to ClinicalTrials.gov are still having problems reporting adverse events data, Deborah Zarin, the Web site's director, told the FDA Risk Communication Advisory Committee Nov. 12